Showing results 3 to 5 of 5
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042 Proceeding/Conference:JTO Clinical and Research Reports | 2021 | |||
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer Journal:New England Journal of Medicine | 2016 | |||
2019 |